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Abstract
Background: Analgesics, including opioids and non-steroid anti-inflammatory drugs reduce postoperative pain.
However, little is known about the quantitative effects of these drugs on cortical activity induced by nociceptive
stimulation. The aim of the present study was to determine the neural activity in response to a nociceptive
stimulus and to investigate the effects of fentanyl (an opioid agonist) and parecoxib (a selective cyclooxygenase-2
inhibitor) on this nociception-induced cortical activity evoked by tail pinch. Extracellular recordings
(electroencephalogram and multi-unit signals) were performed in the area of the anterior cingulate cortex while
intracellular recordings were made in the primary somatosensory cortex. The effects of parecoxib and fentanyl on
induced cortical activity were compared.
Results: Peripheral nociceptive stimulation in anesthetized rats produced an immediate electroencephalogram
(EEG) desynchronization resembling the cortical arousal (low-amplitude, fast-wave activity), while the membrane
potential switched into a persistent depolarization state. The induced cortical activity was abolished by fentanyl,
and the fentanyl’s effect was reversed by the opioid receptor antagonist, naloxone. Parecoxib, on the other hand,
did not significantly affect the neural activity.
Conclusion: Cortical activity was modulated by nociceptive stimulation in anesthetized rats. Fentanyl showed a
strong inhibitory effect on the nociceptive-stimulus induced cortical activity while parecoxib had no significant
effect.
Background
Pain is a complex subjective sensory experience which is
comprised of sensory discrimination, cognitive apprecia-
tion and affective motivation components [1]. The treat-
ment of pain is a fundamental issue in the practice of
anesthesia. However, the mechanisms of pain and
analgesia are unclear. With the development of imaging
technology (e.g., functional magnetic resonance imaging
and positron emission tomography), cortical areas that
are commonly activated by noxious stimuli have been
illuminated. These areas include the primary and sec-
ondary somatosensory cortices (S1, S2), anterior cingu-
late cortex (ACC), insular cortex and motor cortex [2,3].
Electrophysiological studies show that cortical neuronal
activity under anesthesia is associated with an Up-Down
membrane potential fluctuation, while EEG signals are
characterized by large-amplitude and slow-wave activity
[4-6]. It is well known that synapses are highly plastic in
the central nervous system including ACC, and that
long-term changes in synaptic transmission contribute
to different functions of brain including chronic pain.
Long-term potentiation (LTP) is believed to the basis of
learning and memory, and it can also be induced by dif-
ferent protocols or peripheral injury at the spinal cord
dorsal horn [7,8]. Elucidation of the electrophysiological
mechanisms of the neuron in encoding nociceptive
information may provide new advances in the detection
of pain under anesthesia. Despite the effectiveness of
opioid drugs in postoperative pain management, there
are limitations in their use, partly due to tolerance
effects. In addition, opioid drugs can potentially cause
respiratory depression, nausea and vomiting [9]. Non
steroid anti-inflammatory drugs (NSAIDs) have been
used in combination with opioid analgesics to reduce
postoperative opioid administration [10,11]. Parecoxib, a
selective inhibitor of cyclooxygenase-2 (COX-2), can
block prostaglandin biosynthesis associated with
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potential adverse effects of COX-1 inhibition, including
gastroduodenal ulceration and bleeding or impairment
of platelet function [10,11]. However, it has been argued
that parecoxib is lacking in adequate analgesic effects on
postoperative pain [12].
The present study investigates the neuronal activity of
ACC and S1 areas (two regions known for their involve-
ment in pain processing) during noxious stimulation. In
addition, the effect of parecoxib was compared with fen-
tanyl on evoked cortical activity.
Results
Cortical response to nociceptive stimulation
We simultaneously measured extracellular activity in the
ACC and intracellular activity in the S1 region in
response to nociceptive stimulation. We found that both
the ACC and S1 areas were activated by tail pinch in
urethane anesthetized rats (Fig. 1A). To examine
whether the neural activity of other cortical areas could
be altered by nociceptive stimulation, we performed
recordings at V1(primary visual cortex), PtA(parietal
association cortex) and FrA(frontal association cortex),
which presented similar activity to that seen in ACC
and S1 (Fig. 1D and 1E).
The EEG recordings showed a shift from large-ampli-
tude, low-frequency waves (commonly seen in anaesthe-
tized rats) towards low-amplitude, high-frequency waves
(resembling that of awake rats) during tail pinch (Fig.
1A and 1C, upper panels). In addition, the mean firing
rate obtained from multi-unit(MU) recordings was
enhanced and the Down state disappeared (Fig. 1B). The
power spectrum analysis revealed that during tail pinch
the ratio of power within low frequency bands was
markedly decreased (Fig. 1C), along with the decreased
absolute power of each EEG band (Fig. 2A).
Intracellular recordings showed that the membrane
potential (Vm) exhibited a bimodal distribution with Up-
Down transitions in the resting condition. This pattern
quickly switched to a persistent Up state following noci-
ceptive stimulation (Fig. 1A, D and 1E, lower panels;
Fig. 2B). Furthermore, waveform correlation analysis
revealed that highly synchronized activity was observed
between the ACC and S1 recordings in the resting state,
while desynchronization was presented when nociceptive
stimulation was applied (Fig. 2C and 2D). The desyn-
chronization was observed when comparing extracellular
recordings in both the ACC and SI (Fig. 2C right panel,
p < 0.01), and when comparing extracellular recordings
in the ACC with intracellular recordings in SI (Fig. 2D,
Figure 1 Electrophysiological recordings from cortical areas during nociceptive stimulation.A ,u p p e rp a n e l :T r a c eo ft h ee x t r a c e l l u l a r
signal from the ACC, showing that the amplitude was reduced while the frequency was increased when a nociceptive stimulus was applied;
lower panel: Intracellular trace from S1, showing that the Down state disappeared and the membrane potential (Vm) switched to a persistent Up
state during nociceptive stimulation. B: The Multi-Unit signal was filtered from the upper panel in A. The spike firing rate of the MU signal was
increased, and the Down state disappeared under nociceptive stimulation. C, upper panel: the trace filtered from A (upper panel), note that EEG
waves switched to low-amplitude, high-frequency pattern activity; lower panel: The power spectrum of the corresponding EEG (C, upper panel),
showing that the low frequency band was markedly reduced. D: The traces recorded from the ACC (upper panel) and from V1 (lower panel). E:
The traces recorded from PtA (upper panel) and FrA (lower panel). Triangles signify the start and end of nociceptive stimulation. The color bar
represents the proportion of EEG bands.
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trophysiological evidence for extensive alterations in
cortical activity by nociceptive stimulation, as suggested
by previous EEG and imaging studies [2,3,13].
Effects of parecoxib and fentanyl on cortical activity
The effects of parecoxib and fentanyl on cortical activity
in response to acute mechanical pain were compared.
Extracellular recordings at ACC and intracellular
recordings at S1 in urethane anesthetized rats were
obtained. EEG recordings revealed that normalized total
power (Fig. 3A) was decreased, while MF (medial fre-
quency; see Fig. 3B), SEF (95% spectral edge frequency;
see Fig. 3C) and distance of cumulative power distribu-
tion (Fig. 3D) were increased by nociceptive stimulation
compared to the resting state. Fentanyl significantly
inhibited these effects, and moreover, its action was
reversed by naloxone (see Fig. 3). Parecoxib administra-
tion, on the other hand, did not inhibit the observed
response in any of these measures (Fig. 3).
There was a significant decrease in δ band power and
an increase in other band powers when nociceptive sti-
mulation was applied (Fig. 4A and 4B, control group),
and a similar change was observed in the parecoxib
group (Fig. 4A, right panel). However, there were no sig-
nificant changes in any EEG band after fentanyl injected
(fig 4B, middle panel). In addition, naloxone reversed
the action of fentanyl (Fig. 4B, right panel).
Although the Down state was reduced or disappeared
(Fig. 1), nociceptive stimulation did not influence the
spike mean firing rate from MU recordings (Fig. 5A).
However, the firing rate was reduced in some neurons
( F i g .1 Aa n d1 E ;l o w e rp a n e l ) , and this inhibition was
also observed in previous studies [14,15]. We therefore,
further investigated spike firing rate by a Non-uniform
index of spike frequency to evaluate effects of parecoxib
and fentanyl. This measure showed that nociceptive sti-
mulation decreased the “non-uniform index” in control
(untreated) animals and that parecoxib did not inhibit
this response; The response was partially inhibited, how-
ever by fentanyl and again, naloxone abolished the fen-
tanyl effect (Fig. 5B).
Finally, we investigated the Up and Down states under
different conditions in the S1 region. The ratio of time
in the Down state to time in the Up state was reduced
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Figure 2 Changes in EEG, Vm and waveform correlation during nociceptive stimulation. A, left panel: Nociceptive stimulation reduced
normalized total power of each EEG band; right panel: The cumulative power probability of the EEG, was shifted to the right, under nociceptive
stimulation. B, left panel: The distribution of membrane potential (Vm), was bimodally distributed under the resting condition, and unimodally
distributed when nociceptive stimulation was applied; right panel: The cumulative probability of Vm density is plotted before, after and during
nocicptive stimulation. All measures returned to pre-stimulation values after nociceptive stimulation was removed. C and D: Waveform
correlation between the ACC and S1 showing that the correlation coefficient decreased during tail pinch; in C extracellular recordings were
recorded in both regions, in D intracellular recordings were recorded at S1 while extracellular recordings were recorded at ACC. The left panel in
both C and D show a sample correlation coefficient before and during nociceptive stimulation. The right panel plots the group data. Each EEG
power was normalized to the total power of Pre-stimulation values. The correlation coefficient (peak value near zero seconds) was considerably
higher in the resting state than during tail pinch.
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Page 3 of 12and the firing rate of the Up state increased (Fig. 6A, B;
control) during nociceptive stimulation. Administration
of fentanyl reversed these responses while the addition
of naloxone abolished the fentanyl’s effects (Fig. 6A and
6B, right panels). In addition, the distance of membrane
potential distribution was significantly increased during
tail pinch (Fig. 6C; control) and administration of fenta-
nyl significantly inhibited this response. Naloxone was
again able to reverse the fentanyl effect (Fig. 6C, right
panel). Parecoxib had no significant effect on any of
these measures (Fig. 6, left panels).
Fentanyl (30 μg/kg, i.m.) did not significantly influence
heart rate, while respiratory rate was lightly depressed
(Fig. 7, n = 9). Further study showed that there was no
significant change in the index of blood gas, glucose or
hematocrit (see table 1).
Discussion
The present study investigated the neuronal response in
the ACC and S1 area of urethane anesthetized rats dur-
ing acute mechanical noxious stimulation. In addition,
the effects of parecoxib and fentanyl on evoked neuronal
responses were assessed. Acute mechanical stimulation
led to neuronal activation in all cortical areas studied. In
a more detailed investigation using the ACC and S1
areas specifically, we found that peripheral nociceptive
stimulation induced a transition from typical Up and
Down state dynamics to a long-lasting EEG activated
state. In addition, intracellular recordings showed that
membrane potentials were locked into a persistent Up
state during noxious stimulation resulting in a desyn-
chronization among cortical brain areas. Fentanyl suc-
cessfully inhibited the extracellular and intracellular
responses induced by noxious stimulation and naloxone
reversed the fentanyl’ effects. Parecoxib, on the other
hand, had no effect on neuronal response.
Previous studies have shown that EEG waves are
desynchronized when a noxious stimulus is applied to a
lightly anesthetized human or animal [13,16]. EEG
desynchronization along with a significant decrease in
total power and δ and θ band frequency have also been
observed after noxious stimulation in isoflurane anesthe-
tized goats [13]. Results from the present study show
that all cortical areas investigated were activated by nox-
ious stimulation (Fig. 1). This non-specificity in cortical
activation may be restrictedt oa n e s t h e t i z e da n i m a l s .
Previous studies show that this type of total cortical
activation can also be mimicked by stimulation of the
ascending arousal system during anesthetic treatment
B
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Figure 3 The effect of parecoxib and fentanyl is evaluated by EEG parameters. Total power (A) was decreased during nociceptive
stimulation, while MF (B), SEF (C), and the distance of cumulative power distribution (CPD) increased in response to noxious stimulation(D).
Fentanyl (n = 12) significantly inhibited the response in each case and the inhibition was reversed by naloxone (n = 9). Parecoxib had no effect
on the neuronal response to noxious stimulation (n = 11). Total power and distance of cumulative power distribution was normalized to pre-
stimulation values. *P < 0.05, **P < 0.01, #P < 0.001, compared with pre-stim value.
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Page 4 of 12[17,18]. For example, brief electrical stimulation of the
pedunculopontine tegmentum (PPT) or locus coeruleus
under ketamine-xylazine anesthesia typically induced a
prolonged period of desynchronized EEG activity that
was paralleled by a persistent depolarized state of the
membrane potential. These conditions are similar to
that observed in the natural awake state [17,18]. Our
results are consistent with those observed with the PPT
stimulation in that the membrane potential was locked
into a persistent Up state when nociceptive stimulation
was applied to the tail. These findings indicate that the
ascending arousal system can be activated directly by
nociceptive stimulation. In other words, if the nocicep-
tive stimulation had only activated the spinothalamic
tract, then the entire cerebral cortex would not have
been activated. Thus, the present data, together with
existing information indicate that the desynchronization
of EEG or depolarized membrane potential may be an
effective indicator of pain during anesthesia.
Traditional NSAIDs such as acetylsalicylic acid non-
specifically inhibit both COX-1 and COX-2. Parecoxib
on the other hand, is a new selective COX-2 inhibitor,
able to maintain analgesic effects without altering the
homeostatic functions of COX-1 [11,19]. In addition,
parecoxib is injected and is therefore suitable for
patients who cannot take oral medication. In this study,
we systematically compared the analgesic effects of pare-
coxib and fentanyl through electrophysiological
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Figure 4 Group data for relative power of each EEG band recorded from the ACC. δ band power was decreased while other band powers
were increased in response to nociceptive stimulation. A: Parecoxib had no effect on band power response. B: Fentanyl completely inhibited the
band power response to nociceptive stimulation and naloxone reversed its effect. *P < 0.05, **P < 0.01, #P < 0.001.
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Page 5 of 12techniques. We demonstrated that fentanyl successfully
inhibited the electrophysiological profile evoked by noci-
ceptive stimulation, and this inhibition was reversed by
naloxone. Parecoxib, on the other hand, had no effect.
Recent studies have demonstrated that parecoxib is
effective in treating postoperative pain [20,21]. In addi-
tion, the analgesic effects of parecoxib have been
demonstrated through fMRI studies showing a reduction
in acute mechanical pain and mechanical hyperalgesia
induced brain activity [22]. Moreover, other reports on
postoperative analgesic effects of parecoxib, have found
a decrease in pain score and in opioid consumption
[20]. There are a number of possible reasons for the
negative results in our study. First, surgery injury leads
to inflammation and COX-2 is highly expressed in
injured tissue, while acute mechanical stimuli (used in
this study) only activates the Aδ and C fibers without
abnormally high expression of COX-2. Our results are
in line with the results of recent studies reporting no
improvement of postoperative pain management after
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Figure 5 The effects of parecoxib and fentanyl on MU (Multi-Unit) and Non-uniform index of MU recordings. A: Spike mean firing rate
from MU recordings were not altered in the presence of nociceptive stimulation. B: The non-uniform index of MU was decreased when
nociceptive stimulus was applied (control), indicating that the neuronal firing pattern was more uniform under nociceptive stimulation than
during the resting state. Fentanyl partially inhibited this response while parecoxib had no effect. *P < 0.05, **P < 0.01, #P < 0.001.
Peng et al. Molecular Pain 2010, 6:3
http://www.molecularpain.com/content/6/1/3
Page 6 of 12Control Fentanyl Naloxone
0
1
2
3
4
# #
**
Control Parecoxib
0
1
2
3
4
T
r
a
n
s
i
t
i
o
n
 
f
r
e
q
u
e
n
c
y
 
o
f
 
U
p
 
s
t
a
t
e
(
H
z
)
# #
B
 
Control Parecoxib
T
i
m
e
 
r
a
t
i
o
 
o
f
 
D
o
w
n
 
s
t
a
t
e
 
t
o
 
U
p
 
s
t
a
t
e
* *
A Pre-stim
       stim
Post-stim 2.0
1.6
1.2
0.8
0.4
0.0
Control Fentanyl Naloxone
* *
2.0
1.6
1.2
0.8
0.4
0.0
Control Parecoxib
D
i
s
t
a
n
c
e
 
o
f
 
c
u
m
u
l
a
t
i
v
e
 
V
m
 
d
i
s
t
r
i
b
u
t
i
o
n
#
#
C
3.0
2.4
1.8
1.2
0.6
0.0
Control Fentanyl Naloxone
#
# 2.4
2.0
1.6
1.2
0.8
0.4
0.0
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Page 7 of 12discectomy with parecoxib [23]. These studies found
that the timing of parecoxib administration is vital to its
effectiveness: peri-operative administration was more
effective than postoperative administration [23,24].
Another study found that parecoxib inhibited behavioral
changes seen in carrageenan evoked inflammation, but
had no effect in acute pain models such as acetic acid-
induced writhing and the formalin test [25]. COX-2
mRNA and protein in spinal cord was increased for 3-6
h after injection of carrageenan [26], while acetic acid
and formalin induced increases in COX-2 mRNA and
protein lasted less than 60 min. In our study, the analge-
sic effect of parecoxib was tested 20 min after adminis-
tration when there may not have been abnormally high
levels of COX-2 expressed. Therefore, it is possible that
the negative parecoxib findings in the present study may
be due timing of drug administration. Our results,
together with the previous findings suggest that the first
*
Figure 7 The effect of fentanyl on heart rate and respiratory rate. The two upper panels show examples of heart rate and respiratory rate
recordings. The left, lower graph shows that fentanyl did not alter heart rate. The right, lower graph shows that fentanyl had a small but
significant effect on respiratory rate. *P < 0.05.
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ing a procedure, and that treatment should continue
post operation. Our study also suggests that parecoxib
should not be used for analgesia in mechanical pain
without inflammation.
The inhibitory effect of opioids on dorsal horn projec-
tion neurons has been well studied. For example, mor-
phine can inhibit voltage-gated calcium channels of
dorsal root ganglion neurons [27]. In addition, topical
spinal application of 10 μM morphine produces an inhi-
bitory effect on projection neurons of lumbar spinal cord
[28,29]. Previous electrophysiological studies have sug-
gested that ACC pyramidal cells undergo rapid and pro-
longed depolarization after the induction of acute pain,
such as by digit amputation [30]. It is conceivable that
cortical desynchronization induced by mechanical stimu-
lation results in the enhancement Ca
2+ of influx through
voltage-gated Ca
2+ channels and NMDA receptors.
Opioid agonists were shown to inhibit voltage-gated Ca
2+
currents in neurons and reduce excitation by synaptic
inhibition [31]. Recent study has shown that low doses of
fentanyl could block the induction of LTP in rat spinal
cord in vivo [32], which can be explained by the action of
opioid receptors on synaptic transmission: presynaptic
inhibition of Ca
2+ channels and membrane hyperpolari-
zation by activation K
+ channels [31]. So the cortical
desynchronization might also be blocked by the above
mechanisms of fentanyl. In addition, glutamatergic trans-
mission can also be inhibited by opioid agonist, for exam-
ple, morphine intra-basolateral amygdaloid nucleus
injection reduces pain-induced aversion [33]. It is well
known that, fentanyl has significant side effects, including
respiratory depression, which may confound its analgesic
effects [9]. We therefore monitored heart rate and
respiratory rate to exclude the possibility of these effects
as confounding variable. The present results show that
heart and respiratory rates were not greatly affected by
fentanyl administration (Fig. 7), and there was no affect
on blood gas analysis (table 1). However, there was a
slight respiratory depression with fetanyl administration,
possibly leading to disruption in internal homeostasis [9].
In the future it will be necessary to exclude the influence
of respiratory depression on fentanyl’s analgesic effects.
Synaptic and cellular mechanisms of LTP in the ACC
are well studied, which is believed to potentiate the sen-
sory responses after injury. Field recording and whole
cell patch-clamp recording techniques have been used
to study the LTP of excitatory synapse responses in the
ACC [34,35]. NMDA receptors play an important role
in prefrontal cortex including ACC LTP [34], while
NR2A and NR2B subunits contribute to most of the
NMDA receptor currents [35,36]. Gene knockout and
pharmacological methods have shown that calcium-acti-
vated adenylyl cyclases, especially subtype 1 and 8 (AC1,
AC8), contribute to the induction of LTP in the ACC
[37]. In addition, activity-dependent immediate early
genes such as Egr1 and CREB (Cyclic-AMP Response
Element Binding proteins) are suggested to contribute
to synaptic plasticity [38]. Furthermore, the enhanced
synaptic responses persist for a long period in the ACC
neurons after tissue inflammation or amputation [34,39].
The animal model of neuropathic pain shows that post-
synaptic AMPA receptor mediated responses are
enhanced in the ACC synapses, such nerve injury trig-
gered enhancement of postsynaptic responses could be
abolished in AC1 knockout mice [40], suggesting that
AC1 may serve as a potential therapeutic target for
treating neuropathic pain. Recent research has examined
potential changes in NR2B receptors in the ACC with
inflammatory pain, which showed that NR2B receptor
mediated responses are enhanced after peripheral
inflammation. With selective forebrain NMDA NR2B
overexpression in the case of tissue injury and inflam-
mation, the inflammatory pain and allodynia were signif-
icantly enhanced [39,41], providing evidence that
NMDA NR2B receptor is critical for chronic pain.
Changes in NMDA NR2B mediated EPSCs by nerve
injury could also abolished in AC1 lacking mice. ACC is
a critical structure for generating emotional response
and encoding pain affects [42,43]. Short and long-term
plasticities of ACC synapses have been believed to be
the cellular basis for the development of chronic pain
[44,45]. Lesions of the ACC in patients and inhibition of
NMDA receptor/cAMP pathways in the ACC have been
shown to be analgesic in chronic pain conditions [46],
p r o v i d i n gk e yb a s i ce v i d e n c ef o rf u t u r ec h r o n i cp a i n
treatment.
Conclusion
The cortical activity of the ACC and S1 is desynchro-
nized during noxious mechanical stimulation, while the
neural membrane potential is locked in a persistent Up
state. Our study provides a useful model for the detailed
study of the electrophysiology of the cortex under differ-
ent states. The activated cortical response to nociceptive
stimulation in our study provides a measure for moni-
toring analgesia during surgery. The results suggest that
Table 1 Blood gas, Glucose and Hemotacrit values
Control Fentanyl
pH 7.31 ± 0.02 7.28 ± 0.02
PaCO2 (mmHg) 43 ± 2 48 ± 3
PaO2 (mmHg) 98 ± 3 99 ± 4
SO2 96.8 ± 0.4 96.8 ± 0.6
Base excess (mmol/L) -5.3 ± 0.9 -4.6 ± 0.9
Glucose (g/dL) 15.0 ± 0.5 14.2 ± 0.3
Hemotacrit (%) 48.2 ± 1.5 45.9 ± 1.1
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should be avoided. Although parecoxib was not effective
in inhibiting the cortical response to acute pain in our
study, other studies with an alternative dosing schedule
should be conducted.
Materials and methods
Animal preparation
Adult Sprague-Dawley rats weighing 240-330 g were
group housed, 5 per cage and maintained under a 12-h
dark-light cycle at 22 ± 1°C. Food and water were avail-
able ad libitum. All procedures complied with the Ani-
mal Use Committee of Shanghai Institutes for Biological
Sciences, Chinese Academy of Sciences. Following initial
anesthesia with urethane (1.5 g/kg, i.p.), animals were
mounted on a stereotaxic apparatus. Lidocaine was
applied locally to the scalp prior to surgery. A sufficient
level of anesthesia was maintained throughout surgery
such that animals had no spontaneous whisker or eyelid
movement. A ceramic pressure sensor was used to
monitor respiration and heart rate. Rectal temperature
was maintained at 37-38°C through an auto feedback
electrical heating blanket. Supplementary doses (one-
fifth of initial dose) of urethane were given when neces-
sary. Small craniotomies were made for microelectrode
implantation. According to the rat atlas of Paxinos and
Waston [47], stereotaxic coordinates were: (1) for SI, 2.5
mm posterior to Bregma (-2.5 A) and 5.0 mm lateral to
midline (L); (2) for ACC, 2.0 A, 0.8 L and 1.0-3.0 mm
ventral to the brain surface; (3) for V1, -7.0 A, 3.0 L; (4)
for PtA, -4.5 A, 4.0 L; and FrA, -5.0 A, 2.0 L. A 2.0 mm
diameter incision was made at the corresponding areas
by dental drill, and epidural mater was removed to
expose the cortex.
Experimental procedure
For extracellular recordings a tungsten microelectrode
(impedance of approximately 450 KΩ) was slowly low-
ered into the ACC with a microdriver (Narishige) under
a dissecting microscope while a reference electrode was
placed just below the scalp. The extracellular signal (0.1
to 3000 Hz) was acquired at a sampling frequency of 20
KHz and then passed through an amplifier (MODEL
2000, A-M system), digitalized by a MICRO 1401 A/D
converter (Cambridge Electronic Design) and then
stored with Spike 2 software (Cambridge Electronic
Design).
Intracellular recordings from barrel cortical neurons
were performed by sharp glass microelectrodes pulled
from glass capillaries with filament (outer diameter of
1.5 mm). The electrode (filled with 2 M potassium acet-
ate) had a tip resistance of 60-100 MΩ. After removing
the epidural mater, the electrode was advanced to the
surface of brain tissue with a motorized manipulator
(Narishige) under a dissecting microscope. The cortical
exposure was sealed with low-melting agar to reduce
fluctuation of brain tissue when the electrode was low-
ered into the brain. The electrode was slowly advanced
with the microdriver at 3-5 μms t e p s .I n t r a c e l l u l a r
recordings began after ACC extracellular activity was
enhanced by tail pinch. The electrical signal was ampli-
fied by an AxoClamp2B amplifier (Molecular Devices),
converted by a MICRO 1401 and stored for offline ana-
lysis. Data from neurons with a resting membrane
potential below -60 mV and spontaneous spike ampli-
tude > 50 mV were included in the study.
After acquiring a stable extracellular and intracellular
recording, a neuronal response was elicited by pinching
the tail using small forceps (constant force: ~350 g/
mm
2)f o ra b o u t1 5s .T h es t i m u l u sw a sa p p l i e d2o r3
times with an inter-stimulus interval of 5 min. The
effect of parecoxib (20 mg/kg, i.m.) or fentanyl (30 μg/
kg, i.m.) on the mechanical stimulation induced
response was tested, and repeated stimulus was applied
20 min or 5 min after each drug injection, respectively.
Naloxone (30 μg/kg, i.m.) was used to reverse fentanyl’s
action. In addition, abdominal aorta blood was collected
and measured for blood gas analysis from eight rats
before or 5-10 min after fentanyl injection.
Data analysis
Raw signals were visually inspected and artifacts were
deleted before analysis. MATLAB (Mathworks,), Origi-
nLab 8 (OriginLab) and Spike 2 software were used for
data analysis. FFT (fast Fourier transform, Hanning win-
dow) was performed on the EEG data (filtered out at 1-
100 Hz) to obtain a power spectrum from which we cal-
culated the integrations of power within the following
bands [48]: total, 1-100 Hz; δ, 1-4 Hz; θ, 4-8 Hz; a, 8-12
Hz; b, 12-25 Hz; g, 25-100 Hz. For a more specific
description, we plotted the cumulative power distribu-
tion (CPD) curve based on the power spectrum by
directly acquiring MF and SEF (frequency below which
50% and 95% of total power resides, respectively). We
then measured the “distance” of cumulative power dis-
tribution, defined by the area of the region between any
two given cumulative curves. This measure quantifies
the change of power distribution under two correspond-
ing experimental conditions. A similar analysis was used
in describing the change of the membrane potential dis-
tribution from intracellular recordings.
Multi-unit data were extracted from the extracellular
signal through a band-pass filter (600~3000 Hz), and
appropriate thresholds were manually selected for spike
discrimination. To describe the uniformity of the spike
train in the absence and the presence of the nociceptive
stimulus, we defined a “Non-uniform Index” of any
given time period T with a spike number of N as
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where ti stands for the time of the ith spike. This
index adequately caught the distinct characteristics of
the “Up and Down” in contrast to the persistent “Up”
firing patterns, regardless of their overall mean firing
rates.
To collect data from intracellular recordings, we first
distinguished the Up and Down states by comparing the
average membrane potential during a given time win-
dow (~10 ms) with that of a much larger time span (~3
s). We then counted the frequency of membrane poten-
tial transitions between the two states. In addition, as
described above for extracellular recording analysis, the
distance between two cumulative curves was used to
quantify differences between experimental groups.
Statistical analysis
Data were normally distributed and presented as mean
± SEM. Statistical significance was tested with paired t-
tests using p < 0.05 as statistically significant.
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